Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Risk factors associated with severity of eosinophilic otitis media.

Kanazawa H, Yoshida N, Yamamoto H, Hara M, Hasegawa M, Matsuzawa S, Shinnabe A, Iino Y.

Auris Nasus Larynx. 2014 Dec;41(6):513-7. doi: 10.1016/j.anl.2014.08.003. Epub 2014 Sep 6.

PMID:
25199747
2.

Eosinophilic inflammation in the middle ear induces deterioration of bone-conduction hearing level in patients with eosinophilic otitis media.

Iino Y, Usubuchi H, Kodama K, Kanazawa H, Takizawa K, Kanazawa T, Ohta Y.

Otol Neurotol. 2010 Jan;31(1):100-4. doi: 10.1097/MAO.0b013e3181bc3781.

PMID:
19816234
3.

Antigen-specific IgE in middle ear effusion of patients with eosinophilic otitis media.

Kanazawa H, Yoshida N, Shinnabe A, Iino Y.

Ann Allergy Asthma Immunol. 2014 Jul;113(1):88-92. doi: 10.1016/j.anai.2014.04.021. Epub 2014 May 24.

PMID:
24863399
4.

Eosinophil chemoattractants in the middle ear of patients with eosinophilic otitis media.

Iino Y, Kakizaki K, Katano H, Saigusa H, Kanegasaki S.

Clin Exp Allergy. 2005 Oct;35(10):1370-6.

PMID:
16238798
5.

Clinical efficacy of anti-IL-5 monoclonal antibody mepolizumab in the treatment of eosinophilic otitis media.

Iino Y, Takahashi E, Ida S, Kikuchi S.

Auris Nasus Larynx. 2019 Apr;46(2):196-203. doi: 10.1016/j.anl.2018.07.011. Epub 2018 Aug 16.

PMID:
30122651
6.

New Insights into Eosinophilic Otitis Media.

Kanazawa H, Yoshida N, Iino Y.

Curr Allergy Asthma Rep. 2015 Dec;15(12):76. doi: 10.1007/s11882-015-0577-2. Review.

PMID:
26546407
7.

Diagnostic criteria of eosinophilic otitis media, a newly recognized middle ear disease.

Iino Y, Tomioka-Matsutani S, Matsubara A, Nakagawa T, Nonaka M.

Auris Nasus Larynx. 2011 Aug;38(4):456-61. doi: 10.1016/j.anl.2010.11.016. Epub 2011 Jan 19.

PMID:
21251776
8.

Eustachian tube function in patients with eosinophilic otitis media associated with bronchial asthma evaluated by sonotubometry.

Iino Y, Kakizaki K, Saruya S, Katano H, Komiya T, Kodera K, Ohta K.

Arch Otolaryngol Head Neck Surg. 2006 Oct;132(10):1109-14.

PMID:
17043260
9.

Effect of omalizumab on biomarkers in middle ear effusion in patients with eosinophilic otitis media.

Iino Y, Hara M, Hasegawa M, Matsuzawa S, Shinnabe A, Kanazawa H, Yoshida N.

Acta Otolaryngol. 2014 Apr;134(4):366-72. doi: 10.3109/00016489.2013.868601.

PMID:
24628335
10.

Effectiveness of instillation of triamcinolone acetonide into the middle ear for eosinophilic otitis media associated with bronchial asthma.

Iino Y, Nagamine H, Kakizaki K, Komiya T, Katano H, Saruya S, Kodera K.

Ann Allergy Asthma Immunol. 2006 Dec;97(6):761-6.

PMID:
17201235
11.

Successful treatment of eosinophilic otitis media associated with severe bronchial asthma with an anti-IL-5 monoclonal antibody, mepolizumab.

Suzaki I, Kimura Y, Tanaka A, Hirano K, Ishibashi A, Mizuyoshi T, Ando I, Kitajima T, Watanabe S, Hinohira Y, Kobayashi H.

Auris Nasus Larynx. 2019 Feb;46(1):141-146. doi: 10.1016/j.anl.2018.05.007. Epub 2018 Jun 13.

PMID:
29909018
12.

Bone conduction hearing level in patients with eosinophilic otitis media associated with bronchial asthma.

Iino Y, Usubuchi H, Kodama K, Takizawa K, Kanazawa T, Ohta Y.

Otol Neurotol. 2008 Oct;29(7):949-52. doi: 10.1097/MAO.0b013e318185fb0d.

PMID:
18758390
13.

Eosinophilic otitis media is associated with asthma severity and smoking history.

Seo Y, Nonaka M, Tagaya E, Tamaoki J, Yoshihara T.

ORL J Otorhinolaryngol Relat Spec. 2015;77(1):1-9. doi: 10.1159/000370122. Epub 2015 Jan 29.

PMID:
25633710
14.

Eosinophilic otitis media: a new middle ear disease entity.

Iino Y.

Curr Allergy Asthma Rep. 2008 Nov;8(6):525-30. Review.

PMID:
18940145
15.

Eosinophilic otitis media diagnosis using flow cytometric immunophenotyping.

Saliba I, Alzahrani M, Weng X, Bestavros A.

Acta Otolaryngol. 2018 Feb;138(2):110-115. doi: 10.1080/00016489.2017.1385845. Epub 2017 Oct 16.

PMID:
29037099
16.

Clinical efficacy of anti-IgE therapy for eosinophilic otitis media.

Iino Y, Hara M, Hasegawa M, Matsuzawa S, Shinnabe A, Kanazawa H, Yoshida N.

Otol Neurotol. 2012 Sep;33(7):1218-24. doi: 10.1097/MAO.0b013e318263d5b8.

PMID:
22825324
17.

Eosinophil-derived neurotoxin, elastase, and cytokine profile in effusion from eosinophilic otitis media.

Uchimizu H, Matsuwaki Y, Kato M, Otori N, Kojima H.

Allergol Int. 2015 Sep;64 Suppl:S18-23. doi: 10.1016/j.alit.2015.03.007. Epub 2015 Apr 25.

18.

Clinical characteristics of so called eosinophilic otitis media.

Nagamine H, Iino Y, Kojima C, Miyazawa T, Iida T.

Auris Nasus Larynx. 2002 Jan;29(1):19-28.

PMID:
11772486
19.

[Eosinophilic otitis media].

de Jong MA, Smithuis LO, Stokroos RJ.

Ned Tijdschr Geneeskd. 2014;158:A8044. Dutch.

PMID:
25387983
20.

Role of IgE in eosinophilic otitis media.

Iino Y.

Allergol Int. 2010 Sep;59(3):233-238. doi: 10.2332/allergolint.10-RAI-0223. Epub 2010 Jul 25. Review.

Supplemental Content

Support Center